Print | Search | Send-to-Friend | Health Library Home

Lobular Carcinoma in Situ

(LCIS)

by Amy Scholten, MPH

• Definition • Causes • Risk Factors • Symptoms • Diagnosis • Treatment • Prevention
En Español (Spanish Version)
 

Definition

Lobular carcinoma in situ (LCIS) is when there are abnormal cells in the lobules of the breast. The lobules are the part of the breast that produces milk. LCIS is not cancer. However, it can raise the risk of future breast cancer.

 

Causes    TOP

It is not clear what causes LCIS. It is likely due to a change in a gene.

 

Risk Factors    TOP

LCIS is more common in premenopausal women between 40 to 50 years old.

 

Symptoms    TOP

LCIS does not have symptoms.

 

Diagnosis    TOP

LCIS does not appear on imaging tests. It cannot be felt during a breast exam. It is usually found during a biopsy of other nearby breast tissue.

 

Treatment    TOP

LCIS does not require treatment.

The doctor will monitor the breast for changes with:

  • A physical and breast exam every 6 to 12 months
  • A yearly mammogram
 

Prevention    TOP

The risk of breast cancer may be reduced by:

  • Reaching and keeping a healthy weight
  • Regular physical activity
  • Eating a healthful diet
  • Avoiding alcohol or—or limiting it to 1 drink or less per day
RESOURCES:

American Cancer Society
https://www.cancer.org

National Cancer Institute
https://www.cancer.gov

CANADIAN RESOURCES:

Canadian Cancer Society
http://www.cancer.ca

Health Canada
https://www.canada.ca

REFERENCES:

LCIS—lobular carcinoma in situ. Breast Cancer website. Available at:
...(Click grey area to select URL)
Accessed March 19, 2021.

Lobular carcinoma in situ. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/lobular-carcinoma-in-situ. Accessed March 19, 2021.

Lobular carcinoma in situ (LCIS). American Cancer Society website. Available at: https://www.cancer.org/cancer/breast-cancer/non-cancerous-breast-conditions/lobular-carcinoma-in-situ.html. Accessed March 19, 2021.

Wen HY, Brogi E. Lobular carcinoma in situ. Surg Pathol Clin. 2018;11(1):123-145.



Last reviewed January 2021 by EBSCO Medical Review Board Mohei Abouzied, MD, FACP
Last Updated: 3/19/2021

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Copyright ©  EBSCO Information Services
All rights reserved.
Privacy Policy | Editorial Policy